- Home
- ZBRA vs WAT Comparison
ZBRA vs WAT Comparison
Compare ZBRA & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZBRA
- WAT
- Stock Information
- Founded
- ZBRA 1969
- WAT 1958
- Country
- ZBRA United States
- WAT United States
- Employees
- ZBRA N/A
- WAT N/A
- Industry
- ZBRA Industrial Machinery/Components
- WAT Biotechnology: Laboratory Analytical Instruments
- Sector
- ZBRA Industrials
- WAT Industrials
- Exchange
- ZBRA Nasdaq
- WAT Nasdaq
- Market Cap
- ZBRA 16.2B
- WAT 17.4B
- IPO Year
- ZBRA 1991
- WAT 1995
- Fundamental
- Price
- ZBRA $305.01
- WAT $328.54
- Analyst Decision
- ZBRA Buy
- WAT Hold
- Analyst Count
- ZBRA 8
- WAT 13
- Target Price
- ZBRA $351.13
- WAT $375.54
- AVG Volume (30 Days)
- ZBRA 483.8K
- WAT 751.9K
- Earning Date
- ZBRA 10-28-2025
- WAT 11-04-2025
- Dividend Yield
- ZBRA N/A
- WAT N/A
- EPS Growth
- ZBRA 138.37
- WAT 10.77
- EPS
- ZBRA 10.59
- WAT 11.09
- Revenue
- ZBRA $5,190,000,000.00
- WAT $3,046,056,000.00
- Revenue This Year
- ZBRA $8.47
- WAT $7.15
- Revenue Next Year
- ZBRA $7.33
- WAT $6.34
- P/E Ratio
- ZBRA $28.80
- WAT $29.62
- Revenue Growth
- ZBRA 19.12
- WAT 5.89
- 52 Week Low
- ZBRA $205.73
- WAT $275.05
- 52 Week High
- ZBRA $427.76
- WAT $423.56
- Technical
- Relative Strength Index (RSI)
- ZBRA 46.74
- WAT 66.86
- Support Level
- ZBRA $290.56
- WAT $284.52
- Resistance Level
- ZBRA $303.78
- WAT $305.39
- Average True Range (ATR)
- ZBRA 7.13
- WAT 9.27
- MACD
- ZBRA -1.26
- WAT 3.19
- Stochastic Oscillator
- ZBRA 41.67
- WAT 90.05
About ZBRA Zebra Technologies Corporation
Zebra Technologies is a leading provider of automatic identification and data capture technology to enterprises. Its solutions include barcode printers and scanners, mobile computers, and workflow optimization software. The firm primarily serves the retail, transportation logistics, manufacturing, and healthcare markets, designing custom solutions to improve efficiency at its customers.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.